March 24 (Reuters) - Newbury Pharmaceuticals AB
NEWBRY.ST :
* LAPATINIB NEWBURY APPROVED BY THE SWEDISH HEALTH
AUTHORITIES
* MARKETING AUTHORIZATION (MA) OF LAPATINIB NEWBURY 250 MG
FILM-COATED TABLETS IN SWEDEN AS FIRST COUNTRY IN A SCANDINAVIAN
REGISTRATION PROCEDURE
* APPROVALS IN NORWAY AND DENMARK ARE EXPECTED TO FOLLOW
UPON
FINALIZED NATIONAL REVIEWS
Source text for Eikon: ID:nMFN1kH45y
Further company coverage: NEWBRY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))